total knee arthroplasty operation
Conditions
Interventions
Multimodal analgesia group:Continuous catheterization of femoral nerve block + local anesthesia (Lo Pacan) + oxycodone + celecoxib
Ordinary analgesia group:Intravenous analgesia pump block + local anesthesia (Lo Pacan) + Intravenous analgesia pump (tramadol 500-700mg standards: 8mg/kg
Toland ondansetron 5mg)
partial closure (0.25% ropivacaine 80ml), after the surgery sooner or later the two oral oxycodone 330mg+ celecoxib capsules 200mg.
Sponsors
Department of orthopedics, People's Hospital of Karamay City
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: From January 2015 to December 2016 in people's Hospital Department of orthopedics, unilateral joint replacement patients 80 cases as the observation object. Patient younger than 80 years old; No cognitive impairment, communication difficulties or mental and neurological diseases; No alcohol or drug dependence syndrome; no morphine or local anesthetic allergy history; for the non steroidal anti-inflammatory drug allergy history; No liver and kidney dysfunction and coagulation dysfunction; No history of peptic ulcer disease and hemorrhagic disease history; The patients were informed consent, and approval from the hospital ethics committee.
Exclusion criteria
Exclusion criteria: (1) and body mass index (body, mass index, BMI) is greater than 35; (2) with chronic pain, neurological and psychiatric dysfunction or 1 weeks still take a variety of analgesic drugs in patients before operation; (3) with severe coagulopathy, active gastric ulcer or are receiving anticoagulant treatment in patients with; (4) bilateral knee OA or undergoing knee artificial revision arthroplasty patients; (5) the femoral nerve block puncture local infection or known to local anesthesia in patients with drug allergy medication and operation process; (6) with rheumatoid arthritis or severe systemic arthritis patients; (7) can not be a correct understanding and cooperation for VAS pain score and can not master the correct method of using patient controlled analgesia pump for patients; (8) patients before and after operation in an unexpected situation, long time operation, excessive tension and postoperative severe infections are excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS; | — |
Countries
China
Contacts
Public ContactYue Yong
Outcome results
None listed